Immunocore Holdings (IMCR) Change in Acquisitions & Divestments (2022 - 2026)

Immunocore Holdings (IMCR) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 40.0% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.0 million (up 40.0% YoY) and the FY2025 annual result came in at $18.0 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments climbed to $6.0 million in Q1 2026 per IMCR's latest filing, from $2.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for IMCR reached as high as $10.0 million in Q1 2025 and fell as low as $1.9 million in Q4 2022.
• A 3-year average of $5.2 million and a median of $6.0 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The largest YoY upside for Change in Acquisitions & Divestments was 40.0% in 2026 against a maximum downside of 40.0% in 2026.
• Year by year, Change in Acquisitions & Divestments stood at $1.9 million in 2022, then grew by 2.72% to $2.0 million in 2025, then surged by 200.0% to $6.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $6.0 million, $2.0 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.